LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 2 filers reported holding LOXO ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,835,000 | -50.6% | 48,802 | -39.8% | 0.00% | -50.0% |
| Q3 2018 | $13,848,000 | -48.5% | 81,062 | -47.7% | 0.01% | -53.8% |
| Q2 2018 | $26,885,000 | +306.2% | 154,983 | +170.1% | 0.01% | +225.0% |
| Q1 2018 | $6,619,000 | +524.4% | 57,372 | +355.3% | 0.00% | – |
| Q4 2017 | $1,060,000 | -77.4% | 12,600 | -75.3% | 0.00% | -100.0% |
| Q3 2017 | $4,696,000 | +94.2% | 50,977 | +69.1% | 0.00% | +100.0% |
| Q2 2017 | $2,418,000 | +127.5% | 30,151 | +19.4% | 0.00% | +100.0% |
| Q1 2017 | $1,063,000 | +46.4% | 25,257 | -1.0% | 0.00% | 0.0% |
| Q4 2015 | $726,000 | – | 25,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |